from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1697/-

LFCtreatmentdescriptionclass of inhibitor

0.044

Amikacinug/mL Amikacintranslation

0.263

Cap5-10ug/mL Capreomycintranslation

-0.191

Rox10-50 ug/mL Roxithromycintranslation

0.698

SM2-5 ug/mL Streptomycintranslation

-0.292

Tet5-10 ug/mL Tetracyclinetranslation

0.253

Rif0.2-5ug/mL Rifampicintranscription

0.282

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.375

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

2.196

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.413

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.897

Clofazimine10-13 ug/mL Clofaziminerespiration

0.352

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.278

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.476

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.653

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.159

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.068

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.169

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.121

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.588

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.653

KCN5-20 ug/mL Potassium cyaniderespiration

-0.130

NaN30.2-2 mM Sodium aziderespiration

-0.199

Nigericin50 uM Nigericinrespiration

0.909

TRC10-150 ug/mL Triclosanrespiration

-0.489

TRZ10-25 ug/mL Thioridazinerespiration

-1.436

Valinomycin0.5-10 uM Valinomycinrespiration

0.828

ZnSO42 mM ZnSO4respiration

-1.544

menadione6-10 ug/mL Menadionerespiration

-1.550

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.001

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.485

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.367

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-1.071

NRP_1Non-replicating persistence stage 1dosRassociated

1.122

Amp0.2mg/mL AmpicillincellWall

1.181

Cephalexin20-100 ug/mL CephalexincellWall

-0.191

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.020

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.253

EMB10-20 ug/mL EthambutolcellWall

0.887

Eta12-40 ug/mL EthionamidecellWall

0.592

INH0.2-0.4 ug/mL IsoniazidcellWall

0.114

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.629

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.674

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.434

BZA0.12 mg/mL BenzamidearomaticAmides

-0.164

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.433

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.320

H2O24 mM hydrogen peroxideDNAdamaging

-0.187

Levo10 ug/mL LevofloxacinDNAdamaging

0.087

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.574

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.160

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.207

UVUV-irradiationDNAdamaging

-1.774

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.597

Antimycin12.5-50 ug/mL Antimycin A?

0.460

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.116

PA_110-50 ug/mL Antitubercular compound PA-1?

0.124

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.063

PA8240.2-2 ug/mL PA-824?

0.547

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.493

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.721

Verapamil50 uM Verapamil?

0.147

mercaptoethanol2 mM 2-Mercaptoethanol?

0.363

methoxatin10-20 ug/mL Methoxatin?